Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindlesByBruce GilPublishedMay 22, 2024
The Dow jumps 125 points as weak consumer sentiment can't stop the rallyByVinamrata ChaturvediUpdatedMay 10, 2024
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with SanofiByRocio FabbroUpdatedMay 10, 2024
The Dow closes 300 points higher and the S&P 500 looks to break a losing streak as investors wait for AppleByVinamrata ChaturvediUpdatedMay 2, 2024
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine salesByBruce GilUpdatedApril 15, 2024
How worried should we be about the uptick in covid cases? A Johns Hopkins scientist explainsByClarisa DiazPublishedSeptember 11, 2023
Covid could do for ventilation what cholera did for cleaner water systemsByMary HuiPublishedMay 18, 2023
